FK, I share your botheration. Today I bought a few shares.

New Post Public Reply Private Reply Replies (1) Message Board
KenChowder FKAdamF. #159992
692
FK, I share your botheration. Today I bought a few shares. At that moment the Bid was at .26. The Ask, 2500 shares of course, was at .2599. Yes, below the Bid. Not much. But when I put in a Buy order at .26, it went through at .2592, below both the Bid and Ask. I did it again, the Bid and Ask the same, and this time the sale was .2583. And then .2579, twice.

There is no doubt that dropping sales prices while the Bid remains the same (above the sales price and the ask) are an example mean someone is manipulating the share price to seem like it is dropping.

As I'm sure we all know, this kind of crap has been going on for years. But despite our mutual annoyance at the days like today, we also all know that this will not go on forever. The drug is of immense, even untold, value to the human race. At some point soon, the people doing this manipulation WILL have to stop. I would say the release of the data Dr. Jay alluded to -- where it becomes clear that Leron can help shrink tumors, transform immunosuppressive macrophages into tumor-killing ones, and change the tumor microenvironment so ICIs can let the immunity system to destroy tumors -- this will loosen the manipulators' grip, and allow the sp to run freely. Up.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Navigating Early Career Challenges: Strategies for Success

Updated Category News Views 159

Understanding the Challenges of Early Career Professionals As the new generation of professionals prepares to step into the workforce, they often face a variety of challenges. Recent insights from professionals reveal common hurdles that individuals might encounter early in their careers. Understanding these challenges is the first step toward successfully navigating...

Continue Reading
Pharming Takes Strategic Step with Public Offer for Abliva AB

Updated Category News Views 387

Pharming Sets a New Course with Strategic Acquisition Strengthening the Pipeline with a First-in-Disease Asset Pharming Group N.V. has recently made headlines with its ambitious public cash offer for Abliva AB. This strategic acquisition, valued at approximately US$66.1 million, aims to advance Pharming's late-stage pipeline significantly. At the heart of this acquisition...

Continue Reading
Golden Sun Health Tech Launches Joint Venture in Tourism Sector

Updated Category News Views 113

Golden Sun Health Technology Group Limited Ventures into Cultural Tourism Golden Sun Health Technology Group Limited, previously known as Golden Sun Education Group Limited (NASDAQ: GSUN), has made a notable step forward by launching a joint venture aimed at tapping into the cultural tourism market. Through its wholly-owned subsidiary, Shanghai Golden Sun Gongyu Education...

Continue Reading
BlackRock Municipal Income Fund Announces Merger Dates and Changes

Updated Category News Views 520

BlackRock Municipal Income Fund Transition Announcement BlackRock Municipal Income Fund, Inc. (NYSE: MUI, referred to as the “Fund”) is set to undergo an exciting transition. The Fund will change from an exchange-listed closed-end fund to an unlisted continuously-offered closed-end fund, which will conduct quarterly repurchases of its shares. This new venture will be...

Continue Reading
Understand Your Rights: Join CrowdStrike Class Action Today

Updated Category News Views 152

Understanding the CrowdStrike Holdings Class Action Attention shareholders of CrowdStrike Holdings, Inc. (NASDAQ: CRWD): If you acquired shares during the specified class period, it’s important to understand your rights regarding an ongoing class action. Recent developments have raised concerns about the company's operations, particularly in relation to its flagship...

Continue Reading